Peter Hur is a dedicated Health Economics and Outcomes Research professional currently serving as the Director of Worldwide HEOR Oncology at Pfizer. With a strong background in developing HEOR strategies, Peter has led significant research initiatives across various companies, including Bristol-Myers Squibb and Novartis, contributing to the optimization of product market access and value proposition. Peter holds a PharmD from the University of North Carolina Eshelman School of Pharmacy and an MBA from the University of North Carolina at Chapel Hill, complemented by a Bachelor's degree in Mechanical Engineering from the University of Michigan. Currently, Peter is pursuing a Master's degree in Applied Data Science at the University of Michigan.
This person is not in any teams
This person is not in any offices